Pages that link to "Q64132952"
Jump to navigation
Jump to search
The following pages link to Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group (Q64132952):
Displaying 50 items.
- Routine versus selective antifungal administration for control of fungal infections in patients with cancer (Q24193817) (← links)
- Interventions for preventing oral candidiasis for patients with cancer receiving treatment (Q24243005) (← links)
- Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1) (Q26824260) (← links)
- Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review (Q27013923) (← links)
- Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients (Q28080147) (← links)
- Current management of fungal infections. (Q32060457) (← links)
- Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents (Q33253851) (← links)
- Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia (Q33265510) (← links)
- Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant (Q33560077) (← links)
- Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion (Q33691165) (← links)
- Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with leukemia (Q33723595) (← links)
- Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection. (Q33876645) (← links)
- Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction (Q34052696) (← links)
- Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment (Q34145791) (← links)
- Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients. (Q34151170) (← links)
- Canadian clinical practice guidelines for invasive candidiasis in adults (Q34237335) (← links)
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America (Q34532546) (← links)
- Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment (Q34610528) (← links)
- Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update (Q34667166) (← links)
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (Q34936576) (← links)
- Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades (Q35019920) (← links)
- Evidence-based guidelines for empirical therapy of neutropenic fever in Korea (Q35033597) (← links)
- Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications (Q35331234) (← links)
- Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4). (Q35672258) (← links)
- Management of invasive candidiasis in critically ill patients (Q35904821) (← links)
- Empiric antifungal therapy and outcomes in extremely low birth weight infants with invasive candidiasis (Q36049420) (← links)
- Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis (Q36285521) (← links)
- Use of antifungal drugs in hematology (Q36364856) (← links)
- Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection (Q36591360) (← links)
- Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia (Q36759440) (← links)
- Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients (Q36895540) (← links)
- Antifungal management in cancer patients (Q37009912) (← links)
- Current and future therapeutic options in the management of invasive aspergillosis (Q37079099) (← links)
- Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis (Q37268334) (← links)
- Clinical outcomes and prognostic factors of empirical antifungal therapy with itraconazole in the patients with hematological malignancies: a prospective multicenter observational study in Korea. (Q37418841) (← links)
- Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever. (Q37474433) (← links)
- Modern antifungal therapy for neutropenic fever (Q37738437) (← links)
- Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B. (Q38079194) (← links)
- Concise review: next-generation cell therapies to prevent infections in neutropenic patients (Q38193653) (← links)
- Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. (Q39467706) (← links)
- Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan (Q39978940) (← links)
- Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients? (Q40189189) (← links)
- Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study. (Q40241173) (← links)
- Modern antifungal therapy for neutropenic fever (Q40401842) (← links)
- Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea (Q40497071) (← links)
- Empirical therapy for bacterial infections in neutropenic patients (Q40594924) (← links)
- Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors (Q40698634) (← links)
- Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination (Q40709555) (← links)
- Diagnosis and treatment of invasive fungal infections in cancer patients (Q40713803) (← links)
- Febrile neutropenia (Q40713812) (← links)